Bone marrow stroma-supported culture of T-lineage acute lymphoblastic: Leukemic cells predicts treatment outcome in children: A Pediatric Oncology Group study

Leukemia

Volumn 16, Issue 6, 2002, Pages 1121-1126

  Winter, S S ^a   Sweatman, J ^a   Shuster, J J ^b   Link, M P ^c   Amylon, M D ^c   Pullen, J ^d   Camitta, B M ^e   Larson, R S ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b University of Florida   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e Midwest children'S' Cancer Center   (United States)

Author keywords

Bone marrow stroma; Patient outcome; T ALL

Indexed keywords

ADOLESCENT; ADULT; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELL LINE; CELL LINEAGE; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; COCULTURE TECHNIQUES; HUMANS; INFANT; LEUKEMIA, T-CELL, ACUTE; LEUKOCYTE COUNT; NEOPLASM RECURRENCE, LOCAL; STROMAL CELLS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

ASPARAGINASE; CYTARABINE; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG RESPONSE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HYPOTHESIS; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHOBLAST; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STROMA CELL; T CELL LEUKEMIA; TREATMENT OUTCOME;

EID: 85014264324     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402469     Document Type: Article

References (37)

1. Acute lymphoblastic leukemia
2. Childhood leukemias
3. Acute lymphoblastic leukemia
4. Clinical importance of lymphoblasts with T-cell markers in childhood acute lymphoblastic leukemia
5. Biology and treatment of childhood T-Lineage acute lymphoblastic leukemia
6. Immunologic markers in childhood acute lymphocytic leukemia
7. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood
8. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T-cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A Pediatric Oncology Group study
9. Significance of commonly used prognostic factors differs for children with T-cell acute lymphoblastic leukemia (ALL) as compared to those with B-precursor ALL
10. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study
11. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia
12. Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994
13. Diagnostic and prognostic significance of chromosome abnormalities in childhood acute lymphoblastic leukemia
14. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia
15. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome
16. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: A report from the Children's Cancer Group
17. Stroma-supported culture of childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome
18. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia
19. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells
20. Improved quantification of cell survival on stromal monolayers by flow cytometric analyses
21. Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus
22. Apoptosis following interleukin-2 withdrawal from T cells: Evidence for a regulatory role of CD18 (beta 2-integrin) molecules
23. Enhanced T-lineage acute lymphoblastic leukaemia (T-ALL) cell survival on bone marrow stroma requires involvement of LFA-1 and ICAM-1
24. Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A Pediatric Oncology Group study
25. Immunoglobulin-producing Hybrid Cell Lines
26. Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2
27. Adhesion molecules involved in the interactions between early T-cells and mesenchymal bone marrow stromal cells
28. Ins and outs of LFA-1
29. Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium
30. Advances in immunology: T-cell function and migration - Two sides of the same coin
31. High endothelial venules (HEVs): Specialized endothelium for lymphocyte migration
32. Inflammatory skin diseases, T cells, and immune surveillance
33. Human B-cell progenitors and bone marrow microenvironment
34. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms
35. Expression of scatter factor in human bladder carcinoma
36. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function